p16 involvement in primary bladder tumors: Analysis of deletions and mutations

International Journal of Oncology

Volumn 14, Issue 3, 1999, Pages 441-445

  Baud, Eric ^a   Catilina, Pierre ^b   Bignon, Yves Jean ^a  

^a CENTRE JEAN PERRIN   (France)

^b UNIVERSITÉ CLERMONT AUVERGNE   (France)

Author keywords

Bladder cancer; Homozygous deletion; LOH; p16; Point mutation

Indexed keywords

DNA; MICROSATELLITE DNA;

ARTICLE; BLADDER TUMOR; CHROMOSOME 9; GENE DELETION; GENETIC MARKER; GENETICS; HETEROZYGOSITY LOSS; HUMAN; POINT MUTATION; TUMOR SUPPRESSOR GENE;

CHROMOSOMES, HUMAN, PAIR 9; DNA, NEOPLASM; GENES, P16; GENETIC MARKERS; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; POINT MUTATION; SEQUENCE DELETION; URINARY BLADDER NEOPLASMS;

EID: 0033087687     PISSN: 10196439     EISSN: None     Source Type: Journal    
DOI: 10.3892/ijo.14.3.441     Document Type: Article

References (19)

1. Ruppert JM, Tokino K and Sidransky D: Evidence for two bladder cancer suppressor loci on human chromosome 9. Cancer Res 53: 5093-5095, 1993.
2. Orlow I, Lacombe L, Hannon GJ, et al: Deletion of the p15 and p16 genes in human bladder tumors. J Natl Cancer Inst 87: 1524-1529, 1995.
3. Keen AJ and Knowles MA: Definition of two regions of deletion on chromosome 9 in carcinoma of the bladder. Oncogene 9: 2083-2088, 1994.
4. Kamb A, Gruis NA, Weaver-Feldhaus J, Liu Q, Harshman K, Tavtigian SV, Stockert E, Day RS, Johnson BE and Skolnick MH: A cell cycle regulator potentially involved in genesis of many tumor types. Science 146:436-440, 1994.
5. Serrano M, Hannon GJ and Beach D: A new regulatory motif in cell-cycle control causing specific inhibition of cyclin d/CDK4. Nature 366: 704-707, 1993.
6. Serrano M, Lee HW, Chin L, et al: Role of the INK4a locus in tumor suppression and cell mortality. Cell 85: 27-37, 1996.
7. Nevins JR: E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 158: 424-429, 1992.
8. Nobori T, Miura K, Wu DJ, Lois A, Takayabashi K and Carson DA: Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers. Nature 369: 753-756, 1994.
9. Cairns P, Polascik T, Eby Y, Tokino K, Merlo A, Mao L, Herath J, Jenkins R, Westra W, Rutter JL, Buckler A, Gabrielson E, Tockman M, Cho K, Hedrick L, Bova GS, Isaacs W, Koch W, Schwab D and Sidransky D: Frequency of homozygous deletion at p16/CDKN2 in primary human tumours. Nat Genet 11: 210-212, 1995.
10. Mori T, Miura K, Aoki T, Nishihira T, Mori S and Nakamura Y: Frequent somatic mutation of the MTS1/CDK41 (multiple tumor suppressor/cyclin-dependent kinase 4 inhibitor) gene in esophageal squamous cell carcinomas. Cancer Res 54: 3396-3397, 1994.
11. Orlow I, Lianes P, Lacombe L, Dalbagni G, Reuter VE and Cordon-Cardo C: Chromosome 9 allelic losses and microsatellite alterations in human bladder tumors. Cancer Res 54: 2848-2851, 1994.
12. Cairns P, Mao L, Merlo A, Lee DJ, Schwa D, Eby Y, Tokino K, van der Riet P, Blaugrund JE and Sidransky D: Rates of p16 (MTS1) mutations in primary tumors with 9p loss. Science 265: 415-416, 1994.
13. Baud E, Catilina P, Boiteux JP and Bignon YJ: Human bladder cancers and normal bladder mucosa present the same hot spot of heterozygous chromosome 9 deletion. Int J Cancer (In press).
14. Knudson AG: Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68: 820-823, 1971.
15. Balazs M, Carroll P, Kerschmann R, Sauter G and Waldman M: Frequent homozygous deletion of cyclin-dependent kinase inhibitor 2 (MTS1, p16) in superficial bladder cancer detected by fluorescence in situ hybridization. Genes Chromosomes Cancer 19: 84-89, 1997.
16. Williamson MP, Elder PA, Shaw ME, et al: P16 (CDKN2) is a major deletion target at 9p21 in bladder cancer. Hum Mol Genet 4: 1569-1577, 1995.
17. Bartsch D, Shevlin DW, Tung WS, et al: Frequent mutation of CDKN2 in primary pancreatic adenocarcinomas. Genes Chromosomes Cancer 14: 189-195, 1995.
18. Hayashi N, Sugimoto Y, Tsuchiya E, et al: Somatic mutations of the MTS (Multiple Tumor Suppressor) 1/CDK4I (cyclin-dependent-kinase-4 inhibitor) gene in human primary non-small cell lung carcinomas. Biochem Biophys Res Commun 202: 1426-1430, 1994.
19. Quelle DE, Zindy F, Ashmun R and Sherr CJ: Alternative reading frames of the INK4a tumor suppressor gene encode two unrelated proteins capable of inducing cell cycle arrest. Cell 83: 993-1000, 1995.